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Abstract—The minimum histological criterion for the 
diagnostics of Alzheimer’s disease (AD) in tissue is the 
presence of senile plaques and neurofibrillary tangles in 
specific brain locations. The routine procedure of 
morphological analysis implies time-consuming and 
laborious steps including sectioning and staining of 
formalin-fixed paraffin-embedded (FFPE) tissue. We 
developed a multispectral Stokes polarimetric imaging 
approach that allows characterization of FFPE brain tissue 
samples to discern the stages of AD progression without 
sectioning and staining the tissue. The Stokes polarimetry 
approach is highly sensitive to structural alterations of 
brain tissue, particularly to the changes in light scattering 
and birefringence. We present the results of the label-free 
non-destructive screening of FFPE mouse brain tissue and 
show several polarization metrics that demonstrate 
statistically significant differences for tissues at different 
stages of AD.    
 
Index Terms—Optical polarimetry, scattering, 
birefringence, Aβ plaques, Stokes vector.  
I. INTRODUCTION 
LZHEIMER’S disease (AD) is a neurodegenerative 
disease and the most common cause of dementia [1]. 
Presently, the definite diagnosis of AD requires histological 
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analysis of brain tissue (postmortem) to detect the β-amyloid 
(Aβ) plaques and neurofibrillary tangles, the two major 
pathological hallmarks of AD. Senile plaques are composed of 
a dense crystalline nucleus and a corona/halo. The crystalline 
nucleus consists mainly of Aβ peptides, whereas the corona 
resembles degenerating neuronal axons and dendrites, 
inflammatory cells (microglia), astrocytes and more loosely 
packed Aβ  [2], [3]. The Aβ in plaques consists mainly of 40 or 
42 amino acids long peptides (Aβ40, Aβ42) [2], [3]. 
Neurofibrillary tangles are located intraneuronally and are 
composed of coiled hyperphosporylated tau fibrils (PHF – 
paired helical filaments) which are currently detected by 
immunohistochemical staining (IHC) using tau-specific 
antibodies [4]–[6]. Neither plaques nor neurofibrillary tangles 
are adequately detected when only stained with hematoxilin and 
eosin (H&E) [4]–[6]. Silver stainings, e.g. Bielschowsky, 
which detect intracellular neurofibrillary tangles, axial 
cylinders of nerve fibers, and neuronal processes in senile 
plaques, are the most adequate techniques for the histologic 
diagnosis of AD [7]. The contours of neurons and their nuclei 
are impregnated against a light background, whereas in the 
soma of neurons, thin fibers of aggregated neurofibrils are 
revealed. A thin network of axons and their collaterals becomes 
A 
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visible between the cells [8]. Alternatively, the fluorescent dye 
Thioflavin S, which is excited by the blue light and binds to β-
sheets of amyloid fibrils, also detects senile plaques and can 
highlight neurofibrillary tangles [2], [4].  Various IHC methods 
are used in combination with routine techniques (H&E, Nissl 
stain, and silver impregnation methods) [7]. The Aβ in the 
nucleus of senile plaques shows apple-green birefringence 
when stained with the dye Congo red, indicating the presence 
of amyloid β-sheets in polarized light [2], [5].  
In fact, currently used histological techniques are limited by a 
number of critical factors that may occur at any stage of the 
process, e.g. during removal, fixation or processing of tissue, as 
well as during embedding, sectioning, mounting and staining 
procedures [9], [10]. The examples of the factors that may lead 
to the deterioration of the histological images quality are: curls, 
tears, wrinkles, dents and/or stripes acquired during sectioning 
and/or mounting of fixed tissue; uneven dewaxing that may lead 
to uneven staining; cracks and/or distortion of the tissue pattern 
during microtome sectioning of frozen tissue samples; 
insufficient adherence of the tissue sections to the microscopic 
glass and/or deteriorated quality of dye solutions that may also 
lead to uneven staining and significant background staining. 
These artifacts may cause the multiple rounds of cutting and 
staining, incorrect interpretation of the images, or the 
destruction/uselessness of the tissue samples in the end. Thus, 
the current histological techniques are quite demanding, time-
consuming, and laborious; as a result, the sampling is very 
limited. Moreover, the routine procedure provides only a 2D 
view of a tiny tissue fraction, additionally limiting the accuracy 
of the results interpretation and reproducibility. Thus, the result 
of histological analysis depends significantly on the quality of 
the samples preparation at each step and on the pathologist’s 
skills, as only qualitative information is obtained. Currently, the 
studies on the application of machine-learning-based analysis 
methods to interpret histology images are striving to improve 
the accuracy and reliability of diagnostic pathology [11].  
Recent studies have shown promising results in label-free 
imaging of Aβ plaques in thin slices of fixed or frozen brain 
tissue. The examples are stimulated Raman scattering (SRS) 
microscopy [12], Fourier-transform infrared spectroscopy 
(FTIR) [13], polarization-sensitive optical coherence 
microscopy (PS-OCM) [14], diffraction phase microscopy 
(DPM) [15], multiphoton microscopy [16], [17]. It has been 
demonstrated that brain tissue with AD exhibits higher 
inhomogeneity of refractive index, higher scattering coefficient, 
higher birefringence due to parallel alignment of fibrils in Aβ 
plaques and higher anisotropy of scattering [14], [15], [18]. In 
the previous studies, it has been demonstrated that polarimetry-
based techniques have a high potential to implement the label-
free, non-destructive express screening of brain tissues in order 
to facilitate the research on AD diagnostics and treatment [19]–
[21]. 
In the current study, we used multiwavelength Stokes vector 
polarimetry to screen bulk formalin-fixed paraffin-embedded 
(FFPE) mouse brain tissue (brain hemispheres) without 
sectioning or staining to distinguish the severity of β-
amyloidosis by analyzing the polarization properties of the light 
backscattered from the tissue. The considered Stokes vector 
polarimetry approach based on circularly polarized illumination 
has been utilized in previous studies for screening of various 
biological tissues and tissue-like scattering media, e.g. 
detection of cancerous tissue, study of skin biomechanics, and 
optical clearing of biological tissues [22]–[28]. 
II. METHODS AND MATERIALS 
The multiwavelength Stokes-vector imaging system 
developed in-house consists of illumination and detection arms 
and a XY translation stage that allows 2D spatial scanning of 
the sample. The experimental system is shown schematically in 
Fig. 1. In the illumination channel, the radiation produced by 
the supercontinuum fiber laser (Leukos Ltd., France) was 
filtered by the high-speed acousto-optic tunable filter (Leukos 
Ltd., France) in 450-650 nm range. The linearly polarized light 
beam emerging from the filter was transformed into right-
circularly polarized (RHCP) light with the half-wave and 
quarter-wave plates (HWP, QWP) and was focused on the 
surface of a tissue block at 55o angle. The light backscattered 
from the sample was collected by a 20× objective lens at 30⁰ 
angle with a variable distance away from the point of 
incidence (LSD) [22]. A beam splitter (BS) placed in the light 
path split the beam with 10:90 ratio between the CMOS camera 
and the polarimeter respectively. The camera was used to 
control the focus position of the detection arm at the sample’s 
surface. The rest of the beam was directed to the Stokes 
polarimeter (Thorlabs Ltd., USA). The diameter of the incident 
focused laser beam di was ∼15 μm (measured with a laser beam 
profiler (BeamMaster BM-7, Coherent)). The field of view of 
the objective lens in the detection arm dd was 50 μm. The angles 
of incidence and detection were optimized for elimination of 
specular reflection in the detected signal. 
 
Fig. 1. Schematic layout of the Stokes vector polarimetry system 
(AOTF, acousto-optic tunable filter; M, mirror; I, iris; L, lens; OL, 
objective lens). Explanations are given in the text. 
The scanning of the samples was performed over the  
4.5 mm  5.5 mm area with a step 25 µm (in Y) and 5 µm (in X) 
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with the source-detector separation LSD  = 0, 50, 100 µm and the 
wavelengths of the probing illumination λ = 450, 550, 650 nm. 
At each scanning point, the full Stokes vector was measured (S0; 
S1; S2; S3), and the following parameters were calculated: the 
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The paraffin blocks containing unstained fixed brain tissue 
from sacrificed APP-transgenic mice (APPPS-21, APPtg) [29] 
with different stages of β-amyloidosis were screened within the 
current study. The utilized APP-transgenic mouse models 
contain Aβ (see Fig. 2(a,b)); the animals start with Aβ 
deposition at an age of 40 days. In total, 24 brain hemispheres 
of mice of different age were investigated. All protocols of the 
breeding and the use of animals and all study procedures were 
performed in accordance with the 2010/63/EU Directive and 
the Norwegian Food Safety (Mattilsynet). The examined brain 
hemispheres were divided into two groups: less affected tissue 
(group I: 11 samples of animals 50-75 days of age), more 
affected tissue (group II: 13 samples of animals 175-200 days 
of age). Fig. 2(a,b) shows the histological images of brain tissue 
of animals of group I (a-1,a-2) and group II (b-1,b-2). Aβ 
plaques are observed as dark brown spots throughout the brain 
tissue due to IHC staining [30]. The number, size, and density 
of Aβ plaques is significantly higher in group II than in group I. 
Fig. 2(c) shows a photograph of a paraffin block, and Fig. 2(d) 
illustrates the number of samples per group. 
  
Fig. 2. Mouse brain samples. (a-1, a-2, b-1, b-2) Histological images 
of the brain hemispheres and magnified views of the marked areas of 
the samples from group I (a-1, a-2) and group II (b-1, b-2). (c) A 
photograph of a paraffin block. (d) The number of samples per group. 
III. RESULTS AND DISCUSSION 
The results of polarimetric imaging have shown that the 
polarization metrics of backscattered light are significantly 
different for the samples from the two groups. In particular, the 
DoP is found to be higher in most cases for the samples from 
group I than from group II at each incident wavelength and 
source-detector separation. Fig. 3 shows the DoP maps and 
average DoP values of a sample from group I (a) and a sample 
from group II (b), measured at 450 nm incident wavelength with 
different values of source-detector separation: LSD = 0 µm (a-1, 
b-1, c-1), LSD = 50 µm (a-2, b-2, c-2), LSD = 100 µm (a-3, b-3, 
c-3). It was found that the increase of LSD leaded to the decrease 
of the preserved DoP of light backscattered from the brain 
samples from both groups. This is a consequence of the 
enlargement of the sampling volume resulting from the increase 
of LSD. Due to a larger sampling volume, light undergoes a 
higher number of scattering events which depolarize it. It 
should be pointed out that the DoP of light backscattered from 
the brain tissue decreased dramatically with the increase of LSD, 
whereas this parameter remained the same for paraffin (see Fig. 
3(a,b)). This is explained by the low light scattering by paraffin 
compared to scattering by the tissue. The increase of 
depolarization (1–DoP) of light backscattered from paraffin 
was notable at LSD > 250 µm. 
 
Fig. 3. DoP maps for samples from group I (a-1, a-2, a-3) and group II 
(b-1, b-2, b-3) and bar plots of DoP mean value (c-1, c-2, c-3), measured 
at 450 nm incident wavelength with different source-detector 
separations:  LSD = 0 µm (a-1, b-1, c-1), LSD = 50 µm (a-2, b-2, c-2), 
LSD = 100 µm (a-3, b-3, c-3). P-value < 0.001.  
It is observed in Fig. 3(a,b) that the light depolarization by 
the tissue from group I was lower than that of group II. This is 
an indication of the higher light scattering by the tissue from 
group II, compared to group I. Notably, the level of light 
depolarization by the tissue from group II, measured at 
LSD = 0 µm, was equivalent to the level of light depolarization 
by the tissue from group I, measured at LSD = 100 µm. This 
indicates the enhancement of light scattering with the 
progression of the disease that has been also demonstrated in 
previous studies [15]. Thus, it is believed that the higher 
concentration of Aβ protein and its aggregations is responsible 
for the increase of scattering within the brain tissue [18]. 
For the quantitative analysis of all acquired polarization 
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properties, the regions containing brain tissue were selected 
from the DoP image. The selection was performed individually 
for each measurement. The selection of spatial zones in DoP 
images was transferred to images of all other parameters 
obtained at the same measurement. The data inside the marked 
borders were processed and statistically analyzed. 
Fig. 4 shows the comparison of each polarization metric 
(averaged within each sample) measured from the two groups 
of samples at 450 nm incident wavelength with LSD = 0, 50, 
100 µm. The compared polarization characteristics are DoP, 
DoLP, DoCP and three last components of the Stokes vector of 
a completely polarized part of the detected light (i.e., 
normalized by S0 ⋅ DoP) [31]. The Mann-Whitney test was used 
to assess the statistical significance of the differences in the 
considered parameters between the two groups of samples with 
the confidence interval of at least 95%. The limit of P-values is 
listed in the corresponding graphs. Refer to the Supplementary 
document1 for the analogous graphs for the data measured at 
550 and 650 nm incident wavelengths and for the calculated 
P-values of each comparison. 
 
Fig. 4. Comparison of the mean values of (a) DoP (b) DoLP, (c) 
DoCP, (d) S1, (e) S2, (f) S3 for the samples from the two groups, 
measured at 450 nm incident wavelength with LSD = 0, 50, 100 µm. The 
analogous graphs for the data measured at 550, 650 nm incident 
wavelengths could be found in the Supplementary document.  
 
1 Supplementary materials are available in the supporting documents 
/multimedia tab.     
The results presented in Fig. 4 show that the state of 
polarization (SoP) of light backscattered from all samples 
measured with all LSD values was left-handed elliptical 
polarization. The increase of LSD had a significant impact on all 
considered polarization metrics. As the Fig. 4(a) shows, the 
DoP of light backscattered from the tissue naturally decreased 
with the increase of LSD. The same tendency was observed for 
DoLP and DoCP (Fig. 4(b,c)). The DoP, DoLP, DoCP of light 
scattered from the samples from group I were higher than the 
same parameters measured for the samples from group II at 
each measurement configuration (see Fig. 4(a,b,c)). Notably, 
the differences in DoP and DoCP between the two groups of 
samples were statistically significant with every value of LSD; 
the differences in DoLP were statistically significant at 
LSD ≥ 50 µm. The comparison of values of DoLP and DoCP 
demonstrates that the linear polarization was preserved by the 
tissues from both groups better than the circular polarization in 
the same measurement configuration. This phenomena has been 
observed in previous studies for biological tissues measured in 
backscattering configuration; it indicates that the tissue exhibits 
higher Rayleigh scattering than Mie scattering [32], [33]. 
The values of the Stokes vector components S1 and S2 were 
similar at LSD = 0, 50 µm, but demonstrated high dispersion at 
LSD = 100 µm for both groups of samples (see Fig. 4(d,e)). At 
LSD = 0, the values of S1 and S2 were similar for the samples 
from the two groups (see Fig. 4(d,e)). However, at LSD ≥ 50 µm, 
the values of S1 became notably lower for the samples from 
group II than for the samples from group I, while the opposite 
relation was true for S2 (see Fig. 4(d,e)). These differences were 
found statistically significant. The values of S3 grew with the 
increase of LSD; the differences between them for the samples 
from different groups were moderate (see Fig. 4(f)).  
The analysis of DoLP and DoCP decay is shown in Fig. 5. 
The data points were well approximated by a linear fit (adjusted 
R2 > 0.95). It was found that the DoLP decays faster than the 
DoCP with the increase of LSD for both groups of samples. The 
higher relative decay of linear polarization compared to circular 
polarization with the increase of scattering has been also 
demonstrated in previous studies [34]. 
 
Fig. 5. Decline of DoLP and DoCP with the increase of LSD for the two 
groups of samples and linear fit of the data points (450 nm incident 
wavelength). The numbers next to fit curves characterize the slopes. 
Table 1 summarizes the results obtained at 450, 550, 650 nm 
incident wavelengths with LSD = 0, 50, 100 µm. Table 1 shows 
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the differences in Z (the mean values of each measurement 
averaged within a group) of each considered polarimetric 
property between the two groups. The values that illustrated 
statistically significant differences at P<0.05 level are 
highlighted in the table. It is observed that the differences in all 
parameters became larger with the growth of LSD at all 
wavelengths, as the increase of the sampling volume led to the 
increase of the contribution of the polarimetric response of the 
tissue inner structure in the detected signal. The differences in 
the optical properties of the tissue from the two groups were 
therefore manifested more prominently at LSD ≥ 50 µm. 
Fig. 6 demonstrates the Stokes vectors measured from the two 
groups of samples mapped on the Poincaré sphere. It is 
observed that the differences in SoP of light backscattered from 
the samples are attributed mostly to DoP, however, at 
LSD ≥ 50 µm, the distinction in S1–3 is evident (Fig. 6(a,c)).  
 
Fig. 6. Stokes vectors mapped on the Poincaré sphere with respect to 
DoP. (a-1) Full view of the Poincaré sphere with data points measured 
with LSD = 50 µm, λ = 650 nm. (a) Magnification of the sphere in (a-1). 
(b) Magnified part of the Poincaré sphere with data points measured with 
LSD = 0 µm, λ = 450 nm. (c) Magnified part of the Poincaré sphere with 
data points measured with LSD = 100 µm, λ = 650 nm. 
Based on the results shown in Fig. 6(c), the value of 
birefringence was estimated using the relation Δn = δλ ∕ 2πl, 
where l is the average photon pathlength within tissue. For the  
measurement configuration LSD = 100 µm and λ = 650 nm, the 
average photon pathlength was calculated with the aid of Monte 
Carlo computational modeling [35], [36] as ~200 µm. Thus, the 
magnitude of birefringence in brain tissue was estimated as 
(7.6 ± 2.2) ⋅ 10-5 for group I and (1.4 ± 0.4) ⋅ 10-4 for group II. 
The higher magnitude of birefringence observed in the samples 
from group II is explained by the growing presence of Aβ 
plaques in brain tissue with the later stage of AD. The 
birefringence of Aβ plaques has been demonstrated in the 
literature [5], [14], [19]. The obtained values of birefringence 
are in good correlation with the findings presented in previous 
studies [14], [19]. 
To expand the results of our study on human brain tissue, 
additional research needs to be performed. Though there are 
many similarities between the corresponding regions of the 
human and mouse brain in terms of architecture and cell types, 
there are also substantial differences [37], [38]. As the 
birefringence, which causes the phase retardation between 
orthogonally polarized light components, is inherent to the 
fibrous structure of Aβ plaques, it is observed both in mouse 
and human brain tissue [14], [19]. However, for the future 
development of the technique, extensive studies of the 
polarimetric response of human brain tissue should be 
performed. 
IV. SUMMARY AND CONCLUSIONS 
We demonstrate that the use of multiwavelength Stokes 
vector polarimetry allows label-free, contactless, quantitative 
characterization of unstained bulk FFPE mouse brain tissue at 
different stages of AD. The increase of the source-detector 
separation allows achieving higher contrast in the polarization 
properties of light backscattered from the two groups of tissues 
differently affected by AD. It was demonstrated that the total 
DoP, DoLP and DoCP are sensitive to the structural alterations 
at all considered measurement configurations, whereas the 
components of the Stokes vector demonstrate moderate 
differences between the samples from different groups at the 
source-detector separation over 50 µm. The value of 
birefringence for the brain tissue was estimated as 
(7.6 ± 2.2) ⋅ 10-5 for group I and (1.4 ± 0.4) ⋅ 10-4 for group II. 
TABLE I 
THE DIFFERENCES BETWEEN THE MEAN VALUES Z OF DISTRIBUTIONS OF POLARIMETRIC PROPERTIES (IN %).  
 
Incident wavelength λ = 450 nm λ = 550 nm λ = 650 nm 
LSD, µm 0 50 100 0 50 100 0 50 100 





S1 +0.6 –1 –8 +0.6 –2 –18 –0.3 –6 –23 
S2  0 +1 +3 –1 +3 +4 –1 +1 +3 
S3 +9 +5 –7 +4 +4 –8 +0.5 –10 –5 
DoP –12 –28 –29 –10 –26 –26 –12 –24 –22 
DoLP –11 –28 –30 –10 –26 –30 –12 –26 –28 
DoCP –20 –31 –23 –15 –27 –20 –13 –18 –14 
GI: group I, GII: group II. The statistically significant differences at P<0.05 level are highlighted. 
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The higher magnitude of birefringence observed in the samples 
of group II is explained by the growing presence of Aβ plaques 
which exhibit birefringence due to their fibrous substructure. 
The implementation of the described approach into clinical use 
would improve the routine histological analysis procedure by 
allowing express pre-evaluation of the disease stage using non-
stained and non-sectioned blocks of FFPE tissue. Such express 
digital characterization would make the standard histological 
analysis procedure less time-consuming and more cost-
efficient, facilitating the research on AD.  
REFERENCES 
[1] S. Mcgirr, C. Venegas, and A. Swaminathan, “Alzheimers Disease: 
A Brief Review,” J. Exp. Neurol., vol. 1, no. 3, pp. 89–98, 2020, doi: 
10.33696/neurol.1.015. 
[2] L. C. Walker, Amyloid beta plaques, vol. 1, no. 31. 2020. 
[3] R. A. Armstrong, “The molecular biology of senile plaques and 
neurofibrillary tangles in Alzheimer’s disease,” Folia Neuropathol., 
vol. 47, no. 4, pp. 289–299, 2009. 
[4] D. J. Dabbs, Ed., Diagnostic Immunohistochemistry: Theranostic and 
Genomic Applications, 5th Ed. Elsevier, 2019. 
[5] F. Gray, C. Duyckaerts, and U. de Girolami, Eds., Escourolle and 
Poirier’s Manual of Basic Neuropathology. New York: Oxford 
University Press, 2019. 
[6] W. Gomez, R. Morales, V. Maracaja-Coutinho, V. Parra, and M. 
Nassif, “Down syndrome and Alzheimer’s disease: common 
molecular traits beyond the amyloid precursor protein,” Aging, vol. 
12, no. 1, pp. 1011–1033, Jan. 2020, doi: 10.18632/aging.102677. 
[7] I. A. Mavroudis et al., “Morphological Changes of the Human 
Purkinje Cells and Deposition of Neuritic Plaques and Neurofibrillary 
Tangles on the Cerebellar Cortex of Alzheimer’s Disease,” American 
Journal of Alzheimer’s Disease & Other Dementiasr, vol. 25, no. 7, 
pp. 585–591, Nov. 2010, doi: 10.1177/1533317510382892. 
[8] X. Du, X. Wang, and M. Geng, “Alzheimer’s disease hypothesis and 
related therapies,” Transl. Neurodegener., vol. 7, no. 1, p. 2, Dec. 
2018, doi: 10.1186/s40035-018-0107-y. 
[9] S. Taqi, S. Sami, L. Sami, and S. Zaki, “A review of artifacts in 
histopathology,” J. Oral Maxillofac. Pathol., vol. 22, no. 2, p. 279, 
2018, doi: 10.4103/jomfp.JOMFP_125_15. 
[10] A. M. Gown, “Diagnostic Immunohistochemistry: What Can Go 
Wrong and How to Prevent It,” Arch. Pathol. Lab. Med., vol. 140, no. 
9, pp. 893–898, Sep. 2016, doi: 10.5858/arpa.2016-0119-RA. 
[11] K. Bera, K. A. Schalper, D. L. Rimm, V. Velcheti, and A. 
Madabhushi, “Artificial intelligence in digital pathology — new tools 
for diagnosis and precision oncology,” Nat. Rev. Clin. Oncol., vol. 
16, no. 11, pp. 703–715, Nov. 2019, doi: 10.1038/s41571-019-0252-
y. 
[12] M. Ji et al., “Label-free imaging of amyloid plaques in Alzheimer’s 
disease with stimulated Raman scattering microscopy,” Sci. Adv., vol. 
4, no. 11, p. eaat7715, Nov. 2018, doi: 10.1126/sciadv.aat7715. 
[13] C. R. Liao et al., “Synchrotron FTIR reveals lipid around and within 
amyloid plaques in transgenic mice and Alzheimer’s disease brain,” 
Analyst, vol. 138, no. 14, pp. 3991–3997, 2013, doi: 
10.1039/c3an00295k. 
[14] B. Baumann et al., “Visualization of neuritic plaques in Alzheimer’s 
disease by polarization-sensitive optical coherence microscopy,” Sci. 
Rep., vol. 7, no. 1, p. 43477, Apr. 2017, doi: 10.1038/srep43477. 
[15] M. Lee et al., “Label-free optical quantification of structural 
alterations in Alzheimer’s disease,” Sci. Rep., vol. 6, no. 1, p. 31034, 
Aug. 2016, doi: 10.1038/srep31034. 
[16] W. R. Zipfel, R. M. Williams, R. Christie, A. Y. Nikitin, B. T. 
Hyman, and W. W. Webb, “Live tissue intrinsic emission microscopy 
using multiphoton-excited native fluorescence and second harmonic 
generation,” Proc. Natl. Acad. Sci., vol. 100, no. 12, pp. 7075–7080, 
Jun. 2003, doi: 10.1073/pnas.0832308100. 
[17] S. Chakraborty, S.-T. Chen, Y.-T. Hsiao, M.-J. Chiu, and C.-K. Sun, 
“Additive-color multi-harmonic generation microscopy for 
simultaneous label-free differentiation of plaques, tangles, and 
neuronal axons,” Biomed. Opt. Express, vol. 11, no. 2, p. 571, Feb. 
2020, doi: 10.1364/BOE.378447. 
[18] P. J. Marchand et al., “Visible spectrum extended-focus optical 
coherence microscopy for label-free sub-cellular tomography,” 
Biomed. Opt. Express, vol. 8, no. 7, p. 3343, Jul. 2017, doi: 
10.1364/BOE.8.003343. 
[19] L.-W. Jin et al., “Imaging linear birefringence and dichroism in 
cerebral amyloid pathologies,” Proc. Natl. Acad. Sci., vol. 100, no. 
26, pp. 15294–15298, Dec. 2003, doi: 10.1073/pnas.2534647100. 
[20] M. Borovkova et al., “Evaluating β-amyloidosis progression in 
Alzheimer’s disease with Mueller polarimetry,” Biomed. Opt. 
Express, vol. 11, no. 8, p. 4509, Aug. 2020, doi: 
10.1364/BOE.396294. 
[21] P. Schucht et al., “Visualization of White Matter Fiber Tracts of Brain 
Tissue Sections With Wide-Field Imaging Mueller Polarimetry,” 
IEEE Trans. Med. Imaging, vol. 39, no. 12, pp. 4376–4382, Dec. 
2020, doi: 10.1109/TMI.2020.3018439. 
[22] M. A. Borovkova, A. V. Bykov, A. Popov, and I. V. Meglinski, “Role 
of scattering and birefringence in phase retardation revealed by locus 
of Stokes vector on Poincaré sphere,” J. Biomed. Opt., vol. 25, no. 
05, p. 057001, May 2020, doi: 10.1117/1.JBO.25.5.057001. 
[23] V. V. Dremin et al., “Imaging of early stage breast cancer with 
circularly polarized light,” in Tissue Optics and Photonics, Apr. 
2020, no. 11363, p. 1136304, doi: 10.1117/12.2554166. 
[24] M. A. Borovkova et al., “The use of Stokes-Mueller polarimetry for 
assessment of amyloid-β progression in a mouse model of 
Alzheimer’s disease,” in Optical Biopsy XVIII: Toward Real-Time 
Spectroscopic Imaging and Diagnosis, 2020, p. 19, doi: 
10.1117/12.2550795. 
[25] D. Ivanov et al., “Colon cancer detection by using Poincaré sphere 
and 2D polarimetric mapping of ex vivo colon samples,” J. 
Biophoton., vol. 13, no. 8, p. e202000082, May 2020, doi: 
10.1002/jbio.202000082. 
[26] I. Meglinski, C. Macdonald, A. Doronin, and M. Eccles, “Screening 
Cancer Aggressiveness by Using Circularly Polarized Light,” in 
Optics in the Life Sciences, 2013, p. BM2A.4, doi: 
10.1364/BODA.2013.BM2A.4. 
[27] C. Macdonald and I. Meglinski, “Backscattering of circular polarized 
light from a disperse random medium influenced by optical clearing,” 
Laser Phys. Lett., vol. 8, no. 4, pp. 324–328, Apr. 2011, doi: 
10.1002/lapl.201010133. 
[28] B. Kunnen, C. Macdonald, A. Doronin, S. Jacques, M. Eccles, and I. 
Meglinski, “Application of circularly polarized light for non-invasive 
diagnosis of cancerous tissues and turbid tissue-like scattering 
media,” J. Biophoton., vol. 8, no. 4, pp. 317–323, 2015, doi: 
10.1002/jbio.201400104. 
[29] R. Radde et al., “Aβ42‐driven cerebral amyloidosis in transgenic 
mice reveals early and robust pathology,” EMBO Rep., vol. 7, no. 9, 
pp. 940–946, Sep. 2006, doi: 10.1038/sj.embor.7400784. 
[30] J. Steffen et al., “Expression of endogenous mouse APP modulates 
β-amyloid deposition in hAPP-transgenic mice,” Acta Neuropathol. 
Commun., vol. 5, no. 1, p. 49, Dec. 2017, doi: 10.1186/s40478-017-
0448-2. 
[31] R. A. Chipman, “Polarimetry,” in Handbook of Optics Vol. 2, M. 
Bass, Ed. McGraw-Hill, New York, 1994, pp. 22.1-22.37. 
[32] A. Pierangelo et al., “Ex-vivo characterization of human colon cancer 
by Mueller polarimetric imaging,” Opt. Express, vol. 19, no. 2, pp. 
1582–1593, Jan. 2011, doi: 10.1364/OE.19.001582. 
[33] V. Sankaran, J. T. Walsh, and D. J. Maitland, “Comparative study of 
polarized light propagation in biologic tissues,” J. Biomed. Opt., vol. 
7, no. 3, pp. 300–307, 2002, doi: 10.1117/1.1483318. 
[34] N. Ghosh and I. Alex Vitkin, “Tissue polarimetry: concepts, 
challenges, applications, and outlook,” J. Biomed. Opt., vol. 16, no. 
11, p. 110801, Nov. 2011, doi: 10.1117/1.3652896. 
[35] I. V. Meglinski, V. L. Kuzmin, D. Y. Churmakov, and D. A. 
Greenhalgh, “Monte Carlo simulation of coherent effects in multiple 
scattering,” Proc. R. Soc. A Math. Phys. Eng. Sci., vol. 461, no. 2053, 
pp. 43–53, Jan. 2005, doi: 10.1098/rspa.2004.1369. 
[36] A. Doronin, C. Macdonald, and I. Meglinski, “Propagation of 
coherent polarized light in turbid highly scattering medium,” J. 
Biomed. Opt., vol. 19, no. 2, p. 025005, Feb. 2014, doi: 
10.1117/1.JBO.19.2.025005. 
[37] J. Li et al., “Conservation and divergence of vulnerability and 
responses to stressors between human and mouse astrocytes,” Nat. 
Commun., vol. 12, no. 1, p. 3958, Dec. 2021, doi: 10.1038/s41467-
021-24232-3. 
This work is licensed under a Creative Commons Attribution 4.0 License. For more information, see https://creativecommons.org/licenses/by/4.0/
This article has been accepted for publication in a future issue of this journal, but has not been fully edited. Content may change prior to final publication. Citation information: DOI 10.1109/TMI.2021.3129700, IEEE
Transactions on Medical Imaging
7 IEEE TRANSACTIONS ON MEDICAL IMAGING, VOL. xx, NO. x, 2020 
 
[38] R. D. Hodge et al., “Conserved cell types with divergent features in 
human versus mouse cortex,” Nature, vol. 573, no. 7772, pp. 61–68, 
Sep. 2019, doi: 10.1038/s41586-019-1506-7. 
 
